Evidence map›Paper›PMID 33193564›Full record

ArticleFrontiers in genetics2020

Germline

Zhe-Yu Hu, Liping Liu, Ning Xie, Jun Lu, Zhentian Liu, Yu Tang, Yikai Wang, Jianbo Yang, Quchang Ouyang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Onco-Breastomics: An Eco-Evo-Devo Holistic Approach.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Single-Strand Annealing in Cancer.International journal of molecular sciences · 2021
    Review
  10. Fanconi Anemia Pathway Genes Advance Cervical CancerFrontiers in cell and developmental biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Zhe-Yu HuAffiliated Cancer Hospital of Xiangya Medical School, Central South University/Hunan Cancer Hospital, Changsha, China.
Liping LiuAffiliated Cancer Hospital of Xiangya Medical School, Central South University/Hunan Cancer Hospital, Changsha, China.
Ning XieAffiliated Cancer Hospital of Xiangya Medical School, Central South University/Hunan Cancer Hospital, Changsha, China.
Jun LuAffiliated Cancer Hospital of Xiangya Medical School, Central South University/Hunan Cancer Hospital, Changsha, China.
Zhentian LiuGeneplus-Beijing Institute, Beijing, China.
Yu TangAffiliated Cancer Hospital of Xiangya Medical School, Central South University/Hunan Cancer Hospital, Changsha, China.
Yikai WangDepartment of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health, Atlanta, GA, United States.
Jianbo YangAffiliated Cancer Hospital of Xiangya Medical School, Central South University/Hunan Cancer Hospital, Changsha, China.
Quchang OuyangAffiliated Cancer Hospital of Xiangya Medical School, Central South University/Hunan Cancer Hospital, Changsha, China.
Hunan Cancer Hospital · CNCentral South University · CNEmory University · USUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

germline PALB2 mutationhereditary breast cancerloss of heterozygositymutational signaturesomatic mutations

Identifiers

PMID33193564
PMCPMC7482549
OpenAlexW3081618742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.